Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19

Luo J. et al, (2021), Allergy, Asthma & Clinical Immunology, 17

The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism

Chen W. et al, (2021), The Journal of Immunology, 206, 2714 - 2724

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.

Luo J. et al, (2019), The Journal of allergy and clinical immunology, 144, 1722 - 1726.e10

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.

Hardman C. et al, (2019), The Journal of allergy and clinical immunology, 143, 2329 - 2333

Correction: Synergistic activation of pro-inflammatory type-2 CD8 + T lymphocytes by lipid mediators in severe eosinophilic asthma

Hilvering B. et al, (2019), Mucosal Immunology, 12, 581 - 581

Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma

Hilvering B. et al, (2018), Mucosal Immunology, 11, 1408 - 1419

Cytometric Gating Stringency Impacts Studies of Type 2 Innate Lymphoid Cells in Asthma

Hinks TSC. et al, (2017), American Journal of Respiratory Cell and Molecular Biology, 57, 745 - 747

Cysteinyl leukotriene E 4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D 2 and epithelial cytokines

Salimi M. et al, (2017), Journal of Allergy and Clinical Immunology, 140, 1090 - 1100.e11

Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness

Hilvering B. et al, (2017), Allergy, 72, 1202 - 1211

Novel data analysis method for multicolour flow cytometry links variability of multiple markers on single cells to a clinical phenotype.

Tinnevelt GH. et al, (2017), Sci Rep, 7

Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a

Cheung KL. et al, (2016), Journal of Experimental Medicine, 213, 2399 - 2412

Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.

Salimi M. et al, (2016), J Immunol, 196, 45 - 54

Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma

Hilvering B. et al, (2015), Therapeutic Advances in Respiratory Disease, 9, 135 - 145

Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk.

Xue L. et al, (2015), J Allergy Clin Immunol, 135

Prostaglandin D<inf>2</inf>and leukotriene E<inf>4</inf>synergize to stimulate diverse T<inf>H</inf>2 functions and T<inf>H</inf>2 cell/neutrophil crosstalk

Xue L. et al, (2015), Journal of Allergy and Clinical Immunology, 135, 1358 - 1366e11

IL-33–Dependent Th2 Response after Rhinovirus Infection in Asthma: More Information Needed

Hilvering B. et al, (2015), American Journal of Respiratory and Critical Care Medicine, 191, 237 - 237

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.

Xue L. et al, (2014), J Allergy Clin Immunol, 133, 1184 - 1194

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis

Salimi M. et al, (2014), BRITISH JOURNAL OF DERMATOLOGY, 170, E32 - E32

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

Salimi M. et al, (2013), J Exp Med, 210, 2939 - 2950

Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.

Pettipher R. et al, (2012), J Pharmacol Exp Ther, 340, 473 - 482

Load More

Include forthcoming?